Doctors Food Physicians Specialization 
Pharmaceutical Technology
OCTOBER 1, 2022
The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS).
Pharmaceutical Representative Training
DECEMBER 28, 2021
Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarify Health
AUGUST 1, 2022
She’s a physician by training and now specializes in driving Clarify’s product strategy and roadmap to enhance clinical nuance, improve actionability and ensure the most impactful use of social determinants of health (SDoH) insights. Read our Q&A below, where we discuss health equity, battling physician bias and more.
Legacy MEDSearch
JUNE 19, 2023
The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis. Combining advanced algorithms and image analysis techniques assists physicians and healthcare professionals in diagnosis and treatment planning. was founded by two doctors with a mission to “change cardiology with blood flow analysis.”
Clarify Health
AUGUST 1, 2022
She’s a physician by training and now specializes in driving Clarify’s product strategy and roadmap to enhance clinical nuance, improve actionability and ensure the most impactful use of social determinants of health (SDoH) insights. Read our Q&A below, where we discuss health equity, battling physician bias and more.
LEVO Health
OCTOBER 26, 2022
Food & Drug Administration (FDA) classifies medical devices. Class II: requires general controls and special controls with and without exemptions and poses a moderate risk. Consultation and decision-making: where the patient is speaking with their doctor and exploring different options. . They are cleared via a 510(k).
pharmaphorum
NOVEMBER 10, 2022
And so, with Bartosz Arlukwiez, chair of the special committee on beating cancer (BECA) of the European Parliament, unable to attend (although he did provide a pre-recorded message of apology), the panel proceeded into discussions. In health and cancer, as well as Europe’s pharmaceutical strategy – what needs to be focused upon is prevention.
Expert insights. Personalized for you.
97 
Let's personalize your content